ANGO Earnings

Quarterly EPS
$-0.31
Q1 2025
$-0.26
Q2 2025
$-0.11
Q3 2025
$-0.15
Q4 2025
$-0.26
Q1 2026
$-0.15
Q2 2026
$-0.19
Q3 2026
$-0.27
Q4 2026
Latest Revenue86.6M
Latest Net Income-11405000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q4 2026-$0.2786.6M-11405000+8.0%-80.0%
Q3 2026-$0.1978.4M-8084000+8.9%-72.7%
Q2 2026-$0.1579.4M-6350000+9.0%+42.3%
Q1 2026-$0.2675.7M-10903000+12.2%+16.1%
Q4 2025-$0.1580.2M-6050000+12.9%+54.5%
Q3 2025-$0.1172.0M-4407000-4.2%+97.6%
Q2 2025-$0.2672.8M-10738000-7.9%+63.9%
Q1 2025-$0.3167.5M-12798000-14.2%-127.0%
Q4 2024-$0.3371.0M-13449000
Q3 2024-$4.6775.2M-187736000
Q2 2024-$0.7279.1M-29048000
Q1 2024$1.1578.7M45.9M
AngioDynamics (ANGO) — Earnings